Alberto Pugliese
City of Hope Medical Center · Professor of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alberto Pugliese as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:38 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07061574 · A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesCity of Hope Medical Center · recruiting · Type 1 Diabetes, New Onset · study chair
- Ph1/Ph2NCT03243058 · Low-dose IL-2 in Established T1D - The "PROREG" StudyJay S. Skyler · withdrawn · Diabetes Mellitus, Type 1, Diabetes, Diabetes, Autoimmune · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- DYRK1A inhibitors, GLP1 Receptor Agonists and Immunomodulation for Beta Cell Regeneration Therapy in Type 1 DiabetesR01DK141874 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2026 · $868,670 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:38 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.Am J Transplant · 2005291 citationsRCR 7.8
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.J Autoimmun · 2015214 citationsRCR 6.0
- 151 citationsRCR 5.9
- Rituximab selectively suppresses specific islet antibodies.Diabetes · 201171 citationsRCR 1.7
- Brightness, contrast, and color balance of digital versus film retinal images in the age-related eye disease study 2.Invest Ophthalmol Vis Sci · 200860 citationsRCR 2.2
- Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.Am J Transplant · 201240 citationsRCR 1.5
- 39 citationsRCR 3.6
- Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance.Am J Transplant · 200838 citationsRCR 0.9
- 30 citationsRCR 1.3
- Effects of a medetomidine-ketamine combination on Schirmer tear test I results of clinically normal cats.Am J Vet Res · 201616 citationsRCR 1.2